Westpac Banking Corporation (WBC)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 35.68 |
|---|---|
| 52-week range | 33.46 – 43.32 |
| Return, 1 month / 3 months | +2.2% / −1.8% |
| Return, 1 year / 3 years | −5.4% / +99.5% |
| Trend | Below its 200-day average |
| RSI (14) | 58 |
| Volatility (1 year) | 21.1% |
| Worst drawdown (1 year) | -20.0% |
| Average daily value traded | 167.83M AUD |
| Dividend yield | 4.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Westpac Banking Corporation is a bank based in Australia. It provides everyday banking to households, including savings and transaction accounts, home loans and credit cards, and it serves businesses with lending, payments and cash management. The bank also offers institutional banking and wealth management services to corporate and institutional clients. Its customers are mainly individuals, small and medium businesses, and larger organisations across Australia and in selected overseas markets.
Westpac Banking Corporation trades under the code WBC on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Westpac Banking Corporation (WBC) trades on the Australian Securities Exchange in Australia. It last closed at AUD 35.68 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 195 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 5.4% and over the last three months it fell 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.8% | ||
| From 52-week high | -16.9% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.8% | ||
| 6-month return | -7.6% | ||
| 12-month return, skipping the last month | -7.5% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 21.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.0% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 167.83M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 4.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.1% |
|---|---|
| 1 month | +2.2% |
| 3 months | −1.8% |
| 6 months | −7.6% |
| 1 year | −5.4% |
| 3 years | +99.5% |
| 5 years | +80.7% |
Signals
| 50-day / 200-day average | 34.58 / 37.08 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.66 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | AUD 0.7700 |
| 6 Nov 2025 | AUD 0.7700 |
| 8 May 2025 | AUD 0.7600 |
| 7 Nov 2024 | AUD 0.7600 |
| 9 May 2024 | AUD 0.9000 |
| 9 Nov 2023 | AUD 0.7200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.